Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A John Barrett

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2008
T cell therapy in allogeneic stem cell transplantationJ H Frederik Falkenburg, Helen E Heslop, A John Barrett
Hematology. American Society of Hematology. Education Program|November 10, 2001
Achievements in Understanding and Treatment of Myelodysplastic SyndromesEva Hellström-Lindberg, Cheryl Willman, A. John Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2010
Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patientsNishitha Reddy, Katayoun Rezvani, A John Barrett, et al.
Blood|September 6, 2003
Graft-versus-leukemia reactions in allogeneic chimerasHans-Jochem Kolb, Christoph Schmid, A John Barrett, et al.
Cytotherapy|May 27, 2014
Opportunities and limitations of natural killer cells as adoptive therapy for malignant diseaseJames O J Davies, Kate Stringaris, A John Barrett, et al.
Blood|June 28, 2003
A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndromeYogen Saunthararajah, Ryotaro Nakamura, Robert Wesley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiationAnurag K Singh, Bipin N Savani, Paul S Albert, et al.
Haematologica|June 2, 2010
Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndromeWilliam B Clark, Stephen A Strickland, A John Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccinationBipin N Savani, Pamela Stratton, Aarthi Shenoy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantationQuan Le, Aarthi Shenoy, Eleftheria Koklanaris, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2008
T cell therapy in allogeneic stem cell transplantationJ H Frederik Falkenburg, Helen E Heslop, A John Barrett
Hematology. American Society of Hematology. Education Program|November 10, 2001
Achievements in Understanding and Treatment of Myelodysplastic SyndromesEva Hellström-Lindberg, Cheryl Willman, A. John Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 25, 2010
Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patientsNishitha Reddy, Katayoun Rezvani, A John Barrett, et al.
Blood|September 6, 2003
Graft-versus-leukemia reactions in allogeneic chimerasHans-Jochem Kolb, Christoph Schmid, A John Barrett, et al.
Cytotherapy|May 27, 2014
Opportunities and limitations of natural killer cells as adoptive therapy for malignant diseaseJames O J Davies, Kate Stringaris, A John Barrett, et al.
Blood|June 28, 2003
A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndromeYogen Saunthararajah, Ryotaro Nakamura, Robert Wesley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiationAnurag K Singh, Bipin N Savani, Paul S Albert, et al.
Haematologica|June 2, 2010
Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndromeWilliam B Clark, Stephen A Strickland, A John Barrett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2008
Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccinationBipin N Savani, Pamela Stratton, Aarthi Shenoy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantationQuan Le, Aarthi Shenoy, Eleftheria Koklanaris, et al.
Pageof 19